Kenneth Segers

Coagulation factor V and thrombophilia: Background and mechanisms

Kenneth Segers, Björn Dahlbäck, Gerry A. F. Nicolaes · Thrombosis and Haemostasis · 2007 · 157 citations

Immunology, Pathology, Thrombosis +17

Design of protein–membrane interaction inhibitors by virtual ligand screening, proof of concept with the C2 domain of factor V

Kenneth Segers, Olivier Spérandio, M. Sack et al. · Proceedings of the National Academy of Sciences · 2007 · 58 citations · Full text

Proteinlipid Interaction, Drug Target, Factor V +18

Synthesis of novel 5-amino-thiazolo[4,5-d]pyrimidines as E. coli and S. aureus SecA inhibitors

Miyeon Jang, Steven De Jonghe, Kenneth Segers et al. · Bioorganic & Medicinal Chemistry · 2010 · 57 citations

Antimicrobial Drug Discovery, E. Coli, Biochemistry +9

Multimerin 1 binds factor V and activated factor V with high affinity and inhibits thrombin generation

Samira Jeimy, Nola Fuller, Subia Tasneem et al. · Thrombosis and Haemostasis · 2008 · 43 citations

The Role of Thrombin Exosites I and II in the Activation of Human Coagulation Factor V

Kenneth Segers, Björn Dahlbäck, Paul Bock et al. · Journal of Biological Chemistry · 2007 · 36 citations · Full text

Immunology, Molecular Biology, Thrombin Exosite Ii +16